You are viewing: US ACL Graft Market analysis
Part of: ACL Graft Market (Global)

The US ACL Graft Market was valued at $26.69 Million in 2024 and projected to reach to $35.99 Million by 2029, representing a compound annual growth rate of 6.2%. The US ACL Graft Market is positioned for steady growth through 2029, supported by a mature healthcare infrastructure and high incidence of ACL injuries among athletes and active populations.

US ACL Graft Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

US ACL Graft Market Trends and Insights

  • The US market benefits from advanced orthopedic infrastructure, high sports injury prevalence, and strong reimbursement frameworks that drive demand for ACL reconstruction procedures.
  • In 2024, the US represents a mature and well-established market segment within North America, supported by increasing adoption of minimally invasive surgical techniques and superior graft materials. During the forecast period from 2024 to 2029, the US ACL Graft Market is expected to experience steady expansion driven by rising awareness of ACL injuries among athletes and active populations.
  • The US healthcare system's emphasis on quality outcomes and patient recovery has accelerated the adoption of premium graft options, including allograft and synthetic alternatives.
  • Market growth in the US is further supported by ongoing clinical research, technological innovations in graft preservation, and expanding access to orthopedic surgical centers across diverse geographic regions..

Key Market Statistics

  • CAGR (2024-2029) 6.2% CAGR
  • Market Size, 2024 ~USD 26.69 Million
  • Forecast, 2029 ~USD 35.99 Million
  • Country US

US ACL Graft Market Overview

Market Valuation :

The US ACL Graft Market is valued at $26.69 million in 2024, with projected growth to $35.99 million by 2029, demonstrating steady expansion in the orthopedic sector.

Growth Trajectory :

The US market exhibits a CAGR of 6.2% through 2029, driven by increasing ACL reconstruction procedures and adoption of advanced graft technologies in American healthcare facilities.

Infrastructure Advantage :

Advanced orthopedic infrastructure, state-of-the-art surgical facilities, and established clinical protocols position the US as a mature and well-developed market for ACL grafts.

Demand Drivers :

High prevalence of sports-related injuries, robust reimbursement frameworks, and strong healthcare spending support consistent demand for ACL reconstruction procedures across the US.

US ACL Graft Market Dynamics

  • Strong reimbursement policies and insurance coverage for orthopedic procedures continue to facilitate market expansion, while technological advancements in graft materials and surgical techniques enhance procedural outcomes and patient satisfaction. Looking ahead, the market will benefit from increasing awareness of ACL injury prevention and treatment options, growing participation in sports and recreational activities, and rising healthcare expenditures.
  • The integration of minimally invasive surgical techniques and improved graft longevity will further drive adoption rates among US orthopedic surgeons and healthcare institutions..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • The US ACL Graft Market is valued at $26.69 million in 2024 and is expected to reach $35.99 million by 2029 at a 6.2% CAGR.
    • The US market is driven by high sports injury incidence, advanced healthcare infrastructure, and strong insurance reimbursement policies.
    • Premium graft materials and minimally invasive surgical techniques are gaining significant adoption across US orthopedic centers.
    • The US represents a mature, well-regulated market with continuous innovation in graft preservation and surgical methodologies.

    ACL Graft Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment FALLS (Non-Sports Injury)
    Forecast Period 2024-2029
    Growth Rate CAGR of 7.2% from 2024 to 2029
    Largest Segment HOSPITALS & AMBULATORY SURGERY CENTERS (End User)
    Market Size Base Year (Billions) ~USD 0.13 (2024)
    Revenue Forecast (Billions) ~USD 0.18 (2029)
    Segments Covered Type Of Acl Surgery, Age Group, Gender, Injury Type, Sports Injury, Non-Sports Injury, End User

    US ACL Graft Market Report Segmentation

    7 segment dimensions are covered across the global market.

    By Type Of Acl Surgery

    • Acl Revision
    • Primary Acl Reconstruction

    By Age Group

    • 19 Years And Below
    • Above 19 Years

    By Gender

    • Female
    • Male

    By Injury Type

    • Non-Sports Injuries
    • Sports Injuries

    By Sports Injury

    • Basketball
    • Football
    • Other Sports Injuries

    By Non-Sports Injury

    • Falls
    • Other Non-Sports Injuries
    • Road Accidents

    By End User

    • Hospitals & Ambulatory Surgery Centers
    • Hospitals & Ascs
    • Speciality Centers
    • Specialty Centers

    US: ACL GRAFT MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    HOSPITALS & ASCS41.6943.6145.8848.4951.5755.1459.2363.846.8
    SPECIALTY CENTERS8.118.378.699.069.5110.0410.6411.325.4
    TOTAL49.7951.9854.5757.5561.0865.1869.8775.166.6

    Target Audience

    • Orthopedic Device Manufacturers : Need US market sizing and growth forecasts to guide product development, market entry strategies, and competitive positioning in the ACL graft segment.
    • Healthcare Investment Firms : Require detailed US market data and CAGR projections to evaluate investment opportunities in orthopedic companies and assess portfolio performance in the ACL reconstruction space.
    • Hospital & Surgical Center Operators : Seek market insights on ACL procedure demand, reimbursement trends, and patient demographics to optimize surgical capacity planning and procurement strategies.
    • Medical Distributors & Suppliers : Need US-specific market forecasts and competitive analysis to identify growth opportunities, negotiate supplier contracts, and plan inventory management for ACL graft products.
    • Orthopedic Surgeons & Clinical Leaders : Require market trends and technology adoption data to stay informed on emerging graft options, clinical outcomes, and practice management opportunities in the US market.

    Reasons to Buy this Report

    • Market Size & Growth Data : Access precise US market valuation ($26.69M in 2024) and 5-year forecast ($35.99M by 2029) with verified CAGR of 6.2%, enabling accurate business planning and investment decisions.
    • Competitive Landscape Intelligence : Understand the US-specific competitive dynamics, key market players, and their positioning within the mature American orthopedic graft sector to identify opportunities and threats.
    • Reimbursement & Regulatory Insights : Gain detailed knowledge of US insurance coverage, Medicare/Medicaid reimbursement frameworks, and FDA regulations specific to ACL grafts for compliant market entry and pricing strategies.
    • Sports Injury Trend Analysis : Leverage data on US sports injury prevalence, demographic patterns, and healthcare-seeking behavior to target high-opportunity patient segments and geographic markets.
    • Strategic Market Entry Planning : Utilize comprehensive US market insights to develop localized go-to-market strategies, identify distribution channels, and forecast revenue potential for orthopedic graft products.

    Frequently asked questions

    What is the current size of the US ACL Graft Market in 2024?

    The US ACL Graft Market is valued at $26.69 million in 2024, reflecting strong demand for ACL reconstruction procedures across the country.

    What is the projected market size for the US ACL Graft Market by 2029?

    The US ACL Graft Market is projected to reach $35.99 million by 2029, growing at a compound annual growth rate of 6.2%.

    What factors are driving growth in the US ACL Graft Market?

    Growth in the US market is driven by high prevalence of sports-related ACL injuries, advanced orthopedic surgical infrastructure, strong insurance reimbursement, and increasing adoption of premium graft materials.

    Which graft types are most commonly used in the US ACL Graft Market?

    The US market utilizes autografts, allografts, and synthetic grafts, with increasing preference for premium options that offer superior biocompatibility and long-term outcomes.

    How does the US ACL Graft Market compare to other North American regions?

    The US represents the largest and most mature segment within North America, characterized by advanced healthcare infrastructure, higher surgical volumes, and greater adoption of innovative graft technologies.

    RESEARCH METHODOLOGY

    To determine the current size of the ACL graft market, this study engaged in four main activities. A comprehensive study was conducted using secondary research methods to gather data about the market, its parent market, and its peer markets. The next stage involved conducting primary research to confirm these conclusions, assumptions, and sizing with industry experts throughout the value chain. A combination of top-down and bottom-up methods was used to assess the overall market size. The market sizes of segments and subsegments were then estimated using data triangulation techniques and market breakdown.

    The four steps involved in estimating the market size are

    Collecting Secondary Data

    Within the secondary data collection process, a range of secondary sources were reviewed so as to identify and gather data for this study, including regulatory bodies, databases (like D&B Hoovers, Bloomberg Business, and Factiva), white papers, certified publications, articles by well-known authors, annual reports, press releases, and investor presentations of companies.

    Collecting Primary Data

    A thorough method was used in the primary research phase, which involved interviewing a wide range of sources from the supply and demand sides. The purpose of these interviews was to obtain the quantitative and qualitative information needed to put up this report. The main sources of information were industry experts from both core and related sectors, as well as preferred manufacturers, distributors, suppliers, pioneers in technology, and organizations involved in every aspect of this industry's value chain. A variety of primary respondents, including important industry stakeholders, subject-matter experts, C-level executives from crucial market companies, and industry advisers, were carefully questioned in-depth. The goal was to gather and validate important qualitative and quantitative insights and to conduct a thorough assessment of future possibilities.

    A breakdown of the primary respondents is provided below:

    ACL Graft Market Size, and Share

    Note 1: Others include sales, marketing, and product managers.

    Note 2: Tiers of companies are defined based on their total revenue. As of 2023, Tier 1 = >USD 5 billion, Tier 2 = USD 500 million to USD 5 billion, and Tier 3 = < USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    COMPANY NAME

    DESIGNATION

    MTF Biologics (US)

    Area Sales Manager

    AlloSource (US)

    Area Account Manager

    RTI Surgical (US)

    Consultant

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the ACL graft market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    ACL Graft Market Size, and Share

    Data Triangulation

    After arriving at the overall market size applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Allograft anterior cruciate ligament reconstruction is a surgical intervention designed to repair a tear in the anterior cruciate ligament (ACL) of the knee, utilizing donor tissue for grafting.

    A strip of donated tendon is used during allograft anterior cruciate ligament reconstruction surgery to strengthen the injured ACL. Donated tendons are obtained from deceased individuals who gave their permission for their tendons to be used in a way that benefits others.

    Key Stakeholders

    • Manufacturers and Distributors of ACL graft
    • Hospitals
    • Ambulatory Surgery Centers
    • Specialty Clinics
    • Tissue Banks
    • Orthopedic Surgeons and Medical Staff
    • Healthcare Providers
    • Market Research and Consulting Firms
    • Government Associations
    • Venture Capitalists and Investors

    Report Objectives

    • To define, describe, segment, and forecast the ACL graft market by type of ACL surgery, age group, gender, injury type, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To assess the ACL graft market with respect to Porter’s five forces, regulatory landscape, the value chain, the supply chain, ecosystem analysis, patent protection, pricing assessment, key stakeholders, and buying criteria
    • To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall ACL graft market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the market segments with respect to six regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries
    • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
    • To track and analyze company developments such as product launches, product approvals, and other developments
    • To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence

    Available Customizations

    With the given market data, MarketsandMarkets offers customizations to meet the company’s needs. The following customization options are available for the report:

    Geographic Analysis:

    Further breakdown of the ACL graft market into specific countries/regions in Europe, Asia Pacific, Latin America, Middle East & Africa, and GCC Countries.

    Company Information:

    Detailed analysis and profiling of additional market players (up to Five), inclusive of:

    • Business Overview
    • Financial Information
    • Product Portfolio
    • Developments (last three years)

    Note: Some companies are privately owned, and their revenues are unavailable in the public domain. Hence, revenues for privately owned companies will not be included in their profile. In addition, company developments that are not reported in the public domain will not be included.

    Get the Full ACL Graft Market Report

    Full forecast, segment splits, and company analysis for all ACL Graft Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status